From our primary analysis of the TPMI dataset for the Han population, LRP1B mutation showed more significant expression in benign neoplasms than in malignant neoplasms of the brain, suggesting that LRP1B acts as a tumor-suppressor gene (TSG) in benign brain tumors. This evidence concerns the gene LRP1B and benign neoplasm of brain.